120 related articles for article (PubMed ID: 30408648)
1. Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Mar; 83():354-366. PubMed ID: 30408648
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Jul; 88():102915. PubMed ID: 31005784
[TBL] [Abstract][Full Text] [Related]
3. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide.
El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H
Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
[TBL] [Abstract][Full Text] [Related]
5. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers.
Chikhale R; Thorat S; Pant A; Jadhav A; Thatipamula KC; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
Bioorg Med Chem; 2015 Oct; 23(20):6689-713. PubMed ID: 26385444
[TBL] [Abstract][Full Text] [Related]
8. Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels.
Akman D; Denzinger K; Huang S; Lee JT; Nafie JW; Wolber G; Zamponi GW; Armstrong DW; Gündüz MG
Eur J Med Chem; 2022 Dec; 244():114787. PubMed ID: 36209630
[TBL] [Abstract][Full Text] [Related]
9. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics.
Kang S; Cooper G; Dunne SF; Luan CH; James Surmeier D; Silverman RB
Bioorg Med Chem; 2013 Jul; 21(14):4365-73. PubMed ID: 23688558
[TBL] [Abstract][Full Text] [Related]
11. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.
Drígelová M; Tarabová B; Duburs G; Lacinová L
Can J Physiol Pharmacol; 2009 Nov; 87(11):923-32. PubMed ID: 19935900
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction.
Cernecka H; Veizerova L; Mensikova L; Svetlik J; Krenek P
J Pharm Pharmacol; 2012 May; 64(5):735-41. PubMed ID: 22471370
[TBL] [Abstract][Full Text] [Related]
14. Imidazo[1,5-a]pyrimidine and benzo[4,5]imidazo-[1,2-a]pyrimidine derivatives as calcium antagonists.
Alajarin R; Vaquero JJ; Alvarez-Builla J; de Casa-Juana MF; Sunkel C; Priego JG; Gomez-Sal P; Torres R
Bioorg Med Chem; 1994 May; 2(5):323-9. PubMed ID: 7922143
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.
Bladen C; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2014 Jul; 466(7):1355-63. PubMed ID: 24149495
[TBL] [Abstract][Full Text] [Related]
16. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
[TBL] [Abstract][Full Text] [Related]
18. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
19. A novel dihydropyridine with 3-aryl meta-hydroxyl substitution blocks L-type calcium channels in rat cardiomyocytes.
Galvis-Pareja D; Zapata-Torres G; Hidalgo J; Ayala P; Pedrozo Z; Ibarra C; Diaz-Araya G; Hall AR; Vicencio JM; Nuñez-Vergara L; Lavandero S
Toxicol Appl Pharmacol; 2014 Aug; 279(1):53-62. PubMed ID: 24844443
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity.
Cho H; Ueda M; Shima K; Mizuno A; Hayashimatsu M; Ohnaka Y; Takeuchi Y; Hamaguchi M; Aisaka K; Hidaka T
J Med Chem; 1989 Oct; 32(10):2399-406. PubMed ID: 2552119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
